Clinical practice heavily relies on results from randomized controlled trials, which may not reflect completely individual patients. Patient-specific modelling has received increasing attention in recent years. Although still far from clinical application on a daily basis, the potential of this approach is significant. The treatment of advanced heart failure may benefit from a modelling framework to guide device treatment and predict outcome. The role of mechanical circulatory support as a long-term solution is increasing in view of the evolving technology and worsening heart failure patient population. Therefore, a preoperative strategy with the ability to predict the course of events in a simulation setting may be justified. Here we present a heart failure patient discussed at a multidisciplinary team meeting whose outcome was compared with simulations carried out with CARDIOSIM c software to investigate the role of this approach as a planning strategy to guide intervention and predict outcome. The clinical decision process is complex and many factors are involved. Patient-specific modelling may have a role to play as part of a preoperative planning strategy with more quantitative evaluation to smooth decision-making.
INTRODUCTION
Clinical practice relies heavily on rough estimates, experience and results from clinical trials, which may not be directly applicable to individual patients. [1] A patient-specific modelling approach has been the subject of significant interest in recent years in view of its potential [2, 3] although still far from clinical application on a daily basis. [4] Mathematical representation of the cardiovascular system based on pressure-volume (PV) relationship and lumped parameter models can help simulate a wide range of cardiovascular conditions and therapeutic interventions maintaining the ability to run on any personal computer. [5] Their simplicity and versatility makes them suitable for clinical assessment on a daily basis, [6] [7] [8] [9] [10] [11] although the successful application of this method requires specific haemodynamics teaching addressed to clinicians. [10] [11] [12] The treatment of advanced heart failure may benefit from a modelling framework to guide device treatment and predict outcome. The role of a mechanical circulatory support system (MCSS) as a long-term solution is increasing in view of the evolving technology and worsening heart failure patient population. Therefore, a preoperative strategy with the ability to evaluate device suitability and predict outcome in a simulation setting may be justified. A cardiovascular software simulator remains a very useful tool for the analysis of the interactions between a left ventricular assist device (LVAD) and the cardiovascular system. [13, 14] Although a three-dimensional (3-D) model is an ideal choice, its computational power is highly demanding and time consuming with limited practical application at present. [15] The use of one-dimensional (1-D) or lumped (0-D) representations where space dependence either relates to the axial coordinate (one-dimensional) or splits the cardiovascular system in compartments (lumped parameter models) [16] may overcome these limitations.
The time-varying elastance model [17] [18] [19] is a landmark in cardiovascular modelling despite its limitations when used to reproduce the behaviour of the assisted left ventricle. [20] Significant changes in ventricular elastance (VE) occur during support with a displacement pump. Therefore, the elastancecontractility relationship may not work following the insertion of a second pump in the systemic bed. [20] VE changes also develop with rotary pumps where a rising device flow relates to a constant ventricular end-systolic volume (ESV), a reduction in ventricular end-diastolic volume (EDV) and a high increase in left ventricular pressure leading to increased VE to justify its dissociation with contractility. [20] A linear model remains sufficiently accurate [21] [22] [23] and adequate in order to simulate the PV relationship, [24] although cardiovascular multiscale modelling [25] has confirmed the limitations of the time-varying elastance concept in relation to the load-dependence of the end-systolic pressure-volume relationship (ESPVR) highlighting the role of further modelling techniques. [26] [27] [28] [29] To address these shortcomings, a nonlinear time-varying theory [30] with modifications including the inter-ventricular septum and a continuous flow pump [31] is appropriate. Here a unimodal function represents the ESPVR and the Frank-Starling law, making it suitable for the analysis of ventricular interactions with LVAD. Outlet pump modelling using a linearly flow-dependent resistance or dynamic modelling using a time-varying resistance may be suitable for the analysis of pulsatile and continuous flow LVADs. [32, 33] A Lagrange multiplier coupling approach [34] to left ventricular assist device modelling [35] using specific methods [36, 37] addresses the interactions between the device inlet and the ventricle at the expense of increased instability at the interface between the fluid and solid meshes. Alternatively, a fluid-solid left ventricular model coupled with a lumped parameter model [38] [39] [40] [41] [42] can be optimized with high order interpolation at the fluid-solid boundary and obtain simulations of fluid-solid interaction over a complete cardiac cycle during circulatory assistance. [43] Here we present a heart failure patient discussed during MDT meeting whose outcome was compared to the results carried out with CARDIOSIM c software to investigate the role of this approach as a planning strategy to guide intervention and predict outcome.
MATERIALS AND METHODS

Heart model background
The software package CARDIOSIM c is a numerical cardiovascular simulator based on 0-D models for the representation of patho-physiological conditions. The software can be used for clinical decision-making and for educational purposes. [7] The modularity of the software package CARDIOSIM c enables to combine the different modules according to the need of the simulation. Some of the modules reproduce the behaviour of several LVADs, [44] IABP, [45] biventricular assist device, biventricular pacemaker [46] and thoracic artificial lung.
The cardiovascular simulator enables the choice between the original and modified time-varying elastance theory [8] [9] [10] to model the native atrial and ventricular behaviour. This work is based on the module where the left (right) ventricular elastance e lv (t) (e rv (t)) depends on the characteristic elastance in systole E lv,s (E rv,s ) and diastole E lv,d (E rv,d ) and an activation functionē lv (t) (ē rv (t)) as follows: [39] (1) with (2) T represents the heart period (ECG signal period), T T E (T T ) coincides with the end ventricular systole (T-wave peak time). The Appendix (Note: The appendix can be obtained from
Published by Sciedu Press the author and the editor) contains a glossary of symbols, parameters and abbreviations. Left (right) ventricular pressure P lv (t) (P rv (t)) is described using the instantaneous ventricular volume and variable elastance concept as follows: [39] (3)
In Eq. (3) P lv,0 and P rv,0 (V lv,0 and V rv,0 ) are the resting left and right ventricular pressures (volumes) respectively, V * lv (t) (V * rv (t)) is the instantaneous left (right) ventricular free wall volume.
The same approach is used to simulate the behaviour of the atrial chambers, the inter-ventricular (IVS) and the interatrial (IAS) septum.
Using the time-varing elastance model for the interventricular septum, we have the following equation: (4) where e sp is the IVS elastance, E sp,d (E sp,s ) is the IVS diastolic (systolic) elastance andē sp (t) is the activation function as follows: (5) T R represents the R-wave peak time in ECG signal.
When P lv (t) = P rv (t), the instantaneous inter-ventricular septal volume V sp (t) becomes: [47] (6)
The relationship between the instantaneous left (right) ventricular free wall volume and the instantaneous left (right) ventricular volume V lv (t) (V rv (t)) is as follows: (7) From Eq. (3), we obtain:
Inserting Eqs. (8) and (6) in Eq. (7), we obtain:
Rearranging Eq. (9), the instantaneous left (right) ventricular pressure becomes: [48] (10)
Equations (10) Applying the time-varying elastance theory, the left (right) atrial elastance e la (t) (e ra (t)) can be described as: (11) where E la,s (E ra,s ) is the characteristic elastance in systole; E la,d (E ra,d ) represents the characteristic elastance in diastole;ē la (t) (ē ra (t)) is the activation function described by: (12) In ECG signal T P B (T P E ) is the onset (end) of atrial depolarization.
The left and right instantaneous atrial pressures (P la (t) and P ra (t)) are described using the instantaneous atrial volume and elastance concept as follows: [39] (13)
is the instantaneous left (right) atrial free wall volume; V la,0 (P la,0 ) and V ra,0 (P ra,0 ) are the resting left and right atrial volumes (pressures) respectively.
According to the concept of atrial interdependence as previously mentioned, the behaviour of the IAS is described as follows: (14) where e Asp is the IAS elastance,
For the activation function, we have: (15) When P la (t) = P ra (t) the instantaneous IAS volume V Asp (t) becomes:
The instantaneous left (right) atrial volume is obtained as follows: (17) From Eq. (13), we obtain:
Inserting Eqs. (18) , (19) and (16) in Eq. (17), we obtain: (20) Rearranging Eq. (20) , the instantaneous left (right) atrial pressure becomes: [48] (21)
Equations (21) enable the simulation of the interactions between the two atrial chambers. Figure 1 shows the electric analogue of the cardiovascular network used for the simulations. The systemic arterial network (expanded view in Figure 2 ) includes the following sections: aortic, thoracic and abdominal. Each section can be modelled by resistance, inertance and compliance (RLC) elements as described in. [3] The venous compartment is described using resistances and compliance (Rvs 1 , Cvs, Rvs 2 ) neglecting the inertial forces. The pulmonary circulation is composed of the main and the small pulmonary artery compartments modelled with RLC elements. The pulmonary arteriole and capillary sections consist of a resistance Rpar and Rpc respectively. The pulmonary venous bed is modelled with the resistance Rvp and the compliance Cvp. The LVAD takes blood from the left ventricle and ejects it into the aorta. Coronary circulation network is described in. [6] The intrapulmonary bed and the main pulmonary artery are reproduced using RLC elements (Rpam, Lpam and Cpam). The small pulmonary artery tract consisting of the small intrapulmonary arteries proximal to the arterioles is modelled with Rpas, Lpas and Cpas elements. A single resistance (Rpar) describes the behaviour of the pulmonary arteriole compartment. The behaviour of the pulmonary capillary bed is simulated using a single resistance (Rpc). [48] The coronary circulation is modelled using one of modules of the CARDIOSIM c library. [50] The four cardiac valves are considered ideal valves [9, 13] and modelled with resistances and diodes. M V diode and Rli (AV and Rlo) reproduce the behaviour of the mitral (aortic) valve, T V diode and Rri (P V and Rro) reproduce the behaviour of the tricuspid (pulmonary) valve. In Figure 1 , P t represents the mean intra-thoracic pressure.
Circulatory numerical model
The extramural pressure of all the components of the pulmonary circulation and of the lumped elements AT and T T (see Figure 2) is assumed identical to the intra-thoracic pressure, which is a function of time. In our modelling approach, we use instead the mean intra-thoracic pressure defined as: (22) T is the ventilator cycle duration and p t (t) is the instantaneous value of the time-varying thoracic pressure. The extramural pressure of the blood vessels modelled with lumped elements (in the abdominal compartment and systemic venous section) is equal to the intra-abdominal pressure (the steady state pressure within the abdominal cavity). Here, we assume the extramural pressure of the abdominal compartment and the systemic venous section (see Figure 1) to be identical to the ambient pressure. 
Berlin heart INCOR pump numerical model
The INCOR pump is a ventricular assist device specifically designed for long-term support but it is suitable as a bridge to transplant and bridge to recovery. The blood coming from the left ventricle flows into the device all the way through the inlet guide vane, which ensures a laminar inflow to the rotor. The outlet guide vane behind the rotor generates additional pressure with a specially aligned blade directing the blood in the outlet cannula to the aorta. The rotor produces the required pumping work with a rotational speed between 5,000 and 10,000 rpm. The device creates a constant blood flow, which in combination with the native left ventricle leads to pulsatility in the patient. The electric representation of the LVAD [42] integrated in the cardiovascular simulator is showed in Figure 2 . Pressure and flows assume the following equations:
Both inlet and outlet cannulas are modelled with resistance, inertance and compliane. The INCOR pump flow is modelled as: (26) Published by Sciedu Press where: (27) B 0 (B p ) represents the ventricular assist device speed (amplitude) component; ϕ is the phase difference between VAD pulsation and the heart timing; T is the cardiac cycle duration. The INCOR pump setting and the cannula values are reported in Table 1 . The governing equations are first order ordinary differential equations, which have been solved using Euler's method.
CASE HISTORY
In this work, we present a patient with a significant anterior wall myocardial infarction requiring full medical treatment in view of residual severe left ventricular systolic dysfunction with ejection fraction EF = 27%. Further deterioration required the administration of dobutamine infusion and close monitoring. The presence of significant co-morbidities including high body mass index (BMI) made this patient an unsuitable transplant candidate whereas LVAD insertion remained debatable and unlikely to achieve clinical improvement. Repeated measurements using a Swan-Ganz catheter showed high values of the resistance and pulmonary artery pressures (PA). A reduction of RVSWI suggested the need of MCSS for the right ventricle following INCOR application. The outcome of the multidisciplinary team meeting suggested to continue with pharmacological treatment and palliative care. In Table 2 , we have reported the measured parameters with the calculated left ventricular ESV, EDV and VE. 
EXPERIMENTAL METHOD
Firstly, we aimed to simulate the cardiovascular background of this patient and estimate the left ventricular elastance from the available data. Secondly, the simulations included the analysis of the effects induced by the continuous left ventricular blood pump (Berlin Heart INCOR Pump) to understand the potential benefit on the patient condition. Thirdly, additional simulations included the effect induced by the administration of Milrinone, which is a phosphodiesterase type-3-inhibitor used in the immediate postoperative period to reduce right ventricular afterload and increase myocardial contractility. During LVAD assistance, the effects induced by the drug were simulated increasing myocardial contractility by 5% and 10% and reducing pulmonary and systemic vascular resistance by 5% and 10%. Figure 3 shows the screen output from CARDIOSIM c software where the patient diseased status has been reproduced based on right heart catheter measurements on admission and after four days since the commencement of inotropic support as listed in Table 2 . The "Simulation" column in Table 3 shows the haemodynamic values obtained by the numerical simulator.
RESULTS
A left ventricular PV loop is generated considering the mean aortic pressure (BP ≡ P as ) as an approximate value for the end-systolic pressure (P as ≈ P es ) and the left ventricular preload LAP ≡ P la ≈ P ed as an approximate value for the end-diastolic pressure (P ed ) being the left EDV and ESV available.
14 ISSN 2377-9381 E-ISSN 2377-939X An increase in left ventricular ejection fraction is also observed with a decrease in left ventricular end-diastolic (and end-systolic) volume. Table 3 shows the simulation outcome following the administration of Milrinone during LVAD assistance. Results listed in the last two columns have been obtained increasing myocardial contractility by 5% (10%) and reducing pulmonary and systemic vascular resistance by 5% (10%). The overall outcome of the simulation does not show significant haemodynamic improvement in relation to pressure values with only marginal benefit on cardiac output. Figure 4 shows the left and right pressure-volume loop analysis without and with the mechanical assistance in conjunction with Milrinone administration. The effects induced by drug administration during LVAD support have been simulated increasing myocardial contractility by 10.0% and reducing pulmonary and systemic vascular resistance by 10.0%. The left and the right pressure-volume loops (left and right side respectively) in the diseased (A) and assisted (B) conditions are available in the two top panels. A leftward shift of the PV loop with a reduction of ESV and EDV is observed for both ventricles during LVAD support and drug administration. The mean value (calculated during the cardiac cycle) of the flow and pressure during LVAD support is available in the right column.
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DISCUSSION
Interactive software like CARDIOSIM c can simulate the cardiovascular system before and after device intervention in real time and in a controlled setting. Examples are the analysis of the interactions with pulsatile and continuous flow LVADs or the IABP. We believe that CARDIOSIM c is more suitable for clinical application because of its features although we acknowledge the potential of other software like CircAdapt Simulator, HemoLab and Harvi. The CircAdapt Simulator integrates the CircAdapt and TriSeg models [51, 52] with a combined adaptation of chambers and vessels in time leading to re-arrangement of the circulation to achieve a steady solution. HemoLab is an integrated computational environment [53, 54] where a combination of models can be assembled to obtain the systemic response of the cardiovascular system. Harvi is a cardiovascular simulator-based textbook consisting of a key electrical analogue. [55, 56] Patient management in advanced heart failure is very problematic especially when it comes to younger patients. The case discussed here is a typical example of difficult decisionmaking where co-morbidities do play a role during the MDT meeting.
The simulation outcome shows a leftward shift of the left and right PV loops with appropriate ventricular volumes and no suction. In contrast, we have to acknowledge that additional improvement occurs over time making INCOR implantation a suitable option. [57] Considering the likely complications associated to the co-morbidities, the MDT outcome may have been appropriate although additional argument to support MCSS is the recent findings about the "obesity paradox", [58] which is currently quite a controversial subject.
A simulation setting is not a replacement of the clinical decision process but an additional tool towards the most suitable treatment. Many factors influence the clinical decision process including previous experience of similar cases, the presence of co-morbidities that may affect the outcome and the risk of potentially fatal complications.
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Although still far from clinical application on a daily basis, there is an increasing recognition shared by clinicians of the potential benefit that patient-specific modelling may bring to the clinical decision process. [59] To increase confidence towards this approach, a larger clinical study would be the way forward to challenge and validate patient-specific simulations.
The heart failure patient discussed in this article is only an example acting as a feasibility approach taking into account its limitation as the only non-blinded scenario. Further work is currently ongoing with the aim to recruit a number of patients for a prospective analysis of our hypothesis.
CONCLUSION
Patient-specific modelling may become a daily approach to guide intervention and predict outcome. It is important that simulations provide results that clinicians can understand and rely on. Finally, the medical community needs to raise the awareness and promote the appropriate education to allow further progress of a potentially revolutionary approach in patient care.
